Upgrade to SI Premium - Free Trial

Travelers (TRV) PT Raised to $300 at Roth/MKM

October 21, 2024 6:31 AM
Roth/MKM analyst Harry Fond raised the price target on Travelers (NYSE: TRV) to $300.00 (from $240.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles